Regulation of ACAT, an enzyme involved in cholesterol esterification and foam cell formation in vascular walls
Regulation of ACAT, an enzyme involved in cholesterol esterification and foam cell formation in vascular walls
批准号:
10671077
负责人:
MIYAZAKI Akira
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Acyl-coenzyme A cholesterol acyltransferase (ACAT) catalyzes conversion of free cholesterol to cholesteryl ester inside the cells and plays a key role in formation of macrophage-derived foam cells in atherosclerotic lesions. There are two isoforms of ACAT, ACAT-1 and ACAT-2. Using a specific antibody to human ACAT-1, we immunohistochemically demonstrated that ACAT-1 is highly expressed in human atherosclerotic lesions, particularly in macrophage-derived foam cells. Western blotting of cultured human monocyte-macrophages showed that ACAT-1 protein increases during differentiation of monocytes into macrophages. To identify the factors involved in ACAT-1 induction during monocyte-macrophage differentiation, we tested some candidates with THP-1 cells as a model of human monocytes. WhenTHP-1 cells were treated with a physiological concentration of 1,25-dihydroxyvitamin D3, a factor known to stimulate monocytic differentiation, ACAT-1 was substantially induced suggesting that 1,25-dihydroxyvitamin D3 is involved in ACAT-1 induction during monocytic differentiation.Immunohistochemical analysis of human tissues showed that ACAT-1 is highly expressed in macrophages and their related cells such as alveolar macrophages, Kupffer cells and Langerhans cells in the skin. Steroid hormone-producing cells such as adrenocortical cells, granulosa cells and Leydig cells also showed abundant expression of ACAT-1. Immunoelectronmicroscopic observation revealed that ACAT-1 is located in rough endoplasmic reticulum in human macrophages. However, when cells were convened to foam cells with acetylated LDL, ACAT-1 is more diffusely distributed inside the cells forming small vesicles. These vesicles may play some roles in cholesterol esterification by ACAT-1.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
宮崎章ほか: "新規作用機序薬剤の開発動向"日本臨床. 57(12). 2842-2847 (1999)
Akira Miyazaki 等人:“具有新作用机制的药物的开发趋势”,日本临床杂志 57(12) (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
宮崎章ほか: "マクロファージの泡沫化"実験医学. 18(5). 625-630 (2000)
Akira Miyazaki 等人:“巨噬细胞的泡沫化”实验医学 18(5) (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CCY, Chang TY, and Takahashi K: "Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and various tisues"The American Journal of Pathology. 156. 227-236 (2000)
Sakashita N、Miyazaki A、Takeya M、Horiuchi S、Chang CCY、Chang TY 和 Takahashi K:“巨噬细胞和各种组织中人酰基辅酶 A 的定位:胆固醇酰基转移酶 1 (ACAT-1)”美国杂志
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeshi Biwa et al.: "Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor." The Journal of Biological Chemistry. 273. 28305-28313 (1998)
Takeshi Biwa 等人:“氧化低密度脂蛋白诱导小鼠巨噬细胞生长是由粒细胞巨噬细胞集落刺激因子介导的。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
宮崎章ほか: "アシルコエンザイムA:コレステロールアシル基転移酵素(ACAT)アイソザイムとその役割"蛋白質 核酸 酵素. 44(8). 1312-1318 (1999)
Akira Miyazaki 等人:“酰基辅酶 A:胆固醇酰基转移酶 (ACAT) 同工酶及其作用”蛋白质核酸酶 44(8) (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Evaluation and improvement of nitrogen and water use efficiencies in Chinese high-yielding rice cultivars
-
批准号:22580015
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.41万
-
财政年份:2010
-
负责人:MIYAZAKI Akira
-
依托单位:
Regulation of macrophage foam cell formation and atherosclerosis by novel regulatory peptides for cardiovascular system
-
批准号:20591084
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:MIYAZAKI Akira
-
依托单位:
Development of novel molecular conductors based onπ-electron system using self-polarized donor molecules
-
批准号:19550133
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:MIYAZAKI Akira
-
依托单位:
Development of molecular conducting magnets oriented to π-d interaction control
-
批准号:14540530
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2002
-
负责人:MIYAZAKI Akira
-
依托单位:
Regulation of ACAT in multiple risk factor syndrome
-
批准号:14571101
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:MIYAZAKI Akira
-
依托单位:
Regulation of ACAT in diabetes and insuliln resistant
-
批准号:12671118
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MIYAZAKI Akira
-
依托单位:
Studies on the Improvement of Feeding Value of Structural Carbohydrate in Wood by Explosion Treatment
-
批准号:61560303
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1986
-
负责人:MIYAZAKI Akira
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
-
批准号:82372160
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈峰
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
-
批准号:81102247
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:丁晨光
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位: